IMBROGNO EDWARD (VP, Finance and CAO) received a stock award from PDL BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/10/2020ACC: 0000882104-20-000008
Officer· VP, Finance and CAO
Since Jun 2019
+292.21K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
292.21K acquired
Non-Derivative Transactions1
Common stock
Direct
Shares
+292.21K
Price / share
—
Trade value
—
% of position
1307.0%
1/8/2020
22.36K→314.56K
Total
Net shares
+292.21K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 1/8/2020 | A · Award | +292.21K | — | — | 1307.0% | 22.36K | 314.56K |
| Total | +292.21K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported